Deal Snapshot
TAKEDA WINS SHAREHOLDER NOD FOR PROPOSED ACQUISITION OF SHIRE
Thursday 06 December 2018

Shareholders of Japanese drugmaker Takeda Pharmaceutical Company Ltd. (TSX: 4502) have approved proposals related to the company's pending acquisition of Irish drugmaker Shire plc (LON: SHP) at an extraordinary general meeting held this week, the company said.
Takeda's proposal to delegate to the Takeda board the decision regarding the offering terms for the issuance of the new Takeda shares required to implement the proposed acquisition was approved as originally proposed by at least 88% of the votes exercised in respect of this proposal.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 06/12/2018
Target: Shire plc
Country: UK
Deal Size: 62bn (USD)
Sector: Pharmaceuticals
Type: Corporate acquisition
Financing: Cash and Stock
Status: Agreed
Vendor:
Buyer: Takeda Pharmaceutical Company
Comment:
Upon the closing of the transaction, Takeda shareholders will own approximately 50% of the combined group.

Options